
|Videos|January 9, 2023
2022 SUO Annual Meeting recap: Emotional toll of surgical complications and PSMA-PET in prostate cancer
Author(s)Urology Times staff
“I think [it was a] great opportunity to catch up on what is going on with PSMA-PET and theranostics and then also understand that that landscape will change over the near future,” says Kelly L. Stratton, MD, FACS.
Advertisement
In this video, Kelly L. Stratton, MD, FACS, recaps presentations from the 2022 Society of Urologic Oncology Annual Meeting regarding the emotional toll of surgical complications and PSMA-PET in prostate cancer. Stratton is an assistant professor of urologic oncology at the University of Oklahoma, Oklahoma City.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
3
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
4
EV plus pembro approval reframes first conversation in MIBC diagnosis
5













